Autophagy inhibition can overcome radioresistance in breast cancer cells through suppression of TAK1 activation
- Autophagy inhibition can overcome radioresistance in breast cancer cells through suppression of TAK1 activation
- MYUNG WOUL HAN; JONG CHEOL LEE; JUN-YOUNG CHOI; GUI CHUL KIM; HYO WON CHANG; HAE YUN NAM; SEONG WHO KIM; 김상윤
- Autophagy; TAK1; breast cancer; radioresistance
- Issue Date
- Anticancer research
- VOL 34, NO 3, 1449-1455
- Background/Aim: Autophagy is frequently activated in radioresistant cancer cells. In the present study, we evaluated the role of autophagy and transforming growth factor-activated kinase 1 (TAK1) in radioresistance. Materials and Methods: TAK1 phosphorylation in MDA-MB231 breast cancer cells was evaluated by western blotting. The regulatory effects of the TAK1 inhibitor and autophagy inhibitor were assessed by cell morphology, cell survival and induction of apoptosis. Results: Radiation induced the phosphorylation of TAK1, whereas the inhibition of TAK1 activity enhanced the cytotoxicity of radiation in MDA-MB231 cells. Autophagy inhibitors significantly enhanced radiation-induced apoptosis of MDA-MB231 cells. This augmentation in radiosensitivity seemed to result from the suppression of TAK1 activation. Conclusion: Inhibition of autophagy enhanced radiosensitivity through suppression of radiation-induced TAK1 activation, suggesting that the modulation of TAK1-induced autophagy may be a good therapeutic strategy to treat radioresistant breast cancer.
- Appears in Collections:
- KIST Publication > Article
- Files in This Item:
There are no files associated with this item.
- RIS (EndNote)
- XLS (Excel)
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.